Diabetes and endocrinology
Endocrine disorders arise from dysregulated hormone production, leading to excess or deficiency of specific hormones within the body. At the Institute of Medicine, award-winning research in diabetes and endocrinology is conducted, ranging from basic research and clinical and epidemiological studies to high-quality registry-based research of international standing.
Nearly half a billion people worldwide are living with diabetes today, according to the International Diabetes Federation. Despite major advances in research in recent years, many questions remain unanswered. Our diabetes and endocrinology research is aimed at understanding the causes and finding means of prevention and treatment.
Our research in endocrinology
At the Department of Medicine, an outstanding research is conducted on endocrine disorders. Through the Sahlgrenska University hospital, researchers have the opportunity to meet patients and carry out patient-oriented clinical research. The research has a high international status and is considered unique. Our research areas includes:
- Improved diagnosis and treatment of pituitary diseases
- The link between overfunction of the thyroid gland, the immune system and cognitive functions
- The effects of hormones on the immune system and cardiovascular disease
- Hormonal regulation of the brain and recovery after ischemic injury
- The influence of hormones on the development of dementia
- The influence of hormones on the development of osteoporosis
- Improved diagnosis and treatment of adrenal gland diseases, and secondary hypertension due to overproduction of hormones
- New treatments for pituitary tumors
Our research in diabetes
Our scientists conduct basic research, clinical investigations and population studies. Our understanding of diabetes is also growing thanks to our register research. Moreover, we cooperate closely with the pharmaceutical industry to produce new and improved drugs. The goal is to understand what causes diabetes, identify risk factors, find ways of preventing the disease, and develop new treatments and technical aids that make life easier for people living with diabetes today. Another aim is to be able to restore insulin production for people with type 1 diabetes. In type 2 diabetes, the goal is to develop a novel therapeutic approach based on gut microbiota. Our research areas include:
- risk factors for sequelae of diabetes
- blood-sugar-lowering treatments for type 1 and 2 diabetes
- the role of genetics in type 2 diabetes
- ageing and obesity, and how they affect the development of type 2 diabetes
- diabetes in relation to cardiac, vascular and metabolic diseases and disorders
- intestinal bacteria as a cure for type 2 diabetes
Research environments, networks, and ongoing studies
- Centre for Lifestyle Intervention
- Lundberg Laboratory for Diabetes Research
- Wallenberg Laboratory for Cardiovascular and Metabolic Research
Research groups
Group leaders - research groups
- Jeremie Boucher
- Helena Filipsson Nyström
- Silvia Gogg
- Soffia Gudbjörnsdottir
- Per-Anders Jansson
- Gudmundur Johannsson
- Kerstin Landin-Wilhelmsen
- Marcus Lind
- Oskar Ragnarsson
- Ulf Smith
- Johan Svensson
- Åsa Tivesten